nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
|
Kuss, Oliver |
|
|
59 |
10 |
p. 1349-1359 |
artikel |
2 |
Below-the-ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers
|
Meloni, Marco |
|
|
59 |
10 |
p. 1331-1338 |
artikel |
3 |
Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY)
|
Fadini, Gian Paolo |
|
|
59 |
10 |
p. 1317-1330 |
artikel |
4 |
Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes
|
Di Folco, Ugo |
|
|
59 |
10 |
p. 1287-1294 |
artikel |
5 |
Exacerbation of disordered eating behaviors in adolescents with type 1 diabetes during the COVID-19 pandemic: reply
|
Gillon-Keren, Michal |
|
|
59 |
10 |
p. 1397-1398 |
artikel |
6 |
Impact of pharmacological treatment of gestational diabetes on the mode of delivery and birth weight: a nationwide population-based study on a subset of singleton pregnant Portuguese women
|
Ramalho, Diogo |
|
|
59 |
10 |
p. 1361-1368 |
artikel |
7 |
Is HbA1c a valid surrogate for mortality in type 2 diabetes? Evidence from a meta-analysis of randomized trials
|
Baechle, Christina |
|
|
59 |
10 |
p. 1257-1263 |
artikel |
8 |
Lifestyle pattern changes, eating disorders, and sleep quality in diabetes: how are the effects of 18 months of COVID-19 pandemic being felt?
|
Erthal, Isadora Nunes |
|
|
59 |
10 |
p. 1265-1274 |
artikel |
9 |
Remnant cholesterol for the detection of glucose metabolic states in patients with coronary heart disease angina pectoris
|
Wang, Yang |
|
|
59 |
10 |
p. 1339-1347 |
artikel |
10 |
Response to “Symptoms of depression are associated with reduced leisure-time physical activity in adult individuals with type 1 diabetes”
|
Waseem, Maryam |
|
|
59 |
10 |
p. 1395-1396 |
artikel |
11 |
Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
|
Orsi, Emanuela |
|
|
59 |
10 |
p. 1369-1381 |
artikel |
12 |
SARS-CoV-2 Omicron symptoms and adverse effects of GLP-1 RA therapy
|
Jensterle, Mojca |
|
|
59 |
10 |
p. 1383-1384 |
artikel |
13 |
SGLT2-inhibitors and euglycemic diabetic ketoacidosis in COVID-19 pandemic era: a case report
|
Secinaro, Enzo |
|
|
59 |
10 |
p. 1391-1394 |
artikel |
14 |
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control
|
Lepore, Giuseppe |
|
|
59 |
10 |
p. 1309-1315 |
artikel |
15 |
The effect of gestational diabetes on the fracture risk after pregnancy: a nationwide register-based study
|
Vaajala, Matias |
|
|
59 |
10 |
p. 1385-1389 |
artikel |
16 |
The potential mechanism of Liu–Wei–Di–Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism
|
Yi, Zi-yang |
|
|
59 |
10 |
p. 1295-1308 |
artikel |
17 |
XAF1 overexpression exacerbates diabetes by promoting pancreatic β-cell apoptosis
|
Nishimura, Yuki |
|
|
59 |
10 |
p. 1275-1286 |
artikel |